Revance Therapeutics Inc - צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים RVNC

The investment potential of Revance Therapeutics (RVNC) is based on outsourcing production and logistics to external partners. Year-over-year revenue dynamics over the last 12 months confirm this trend, with the indicator value standing at 97.00. Growth is driven by physician loyalty to the long-acting Daxxify and the implementation of robotic filling lines with AI-driven purity control, ensuring high product quality.
Revance Therapeutics Inc (RVNC) - פילוחי מדדים ודוחות פיננסיים

This indicator measures the percentage change in revenue over the last 12 months relative to the same period last year, allowing investors to filter out short-term noise and assess the true pace of business expansion. By analyzing the rolling 12-month sales growth rate year-over-year, one can track the impact of Daxxify filling line robotization and the implementation of AI control on the real scalability of operating revenues at Revance Therapeutics (RVNC).